Advanced Strategic Nanocarriers Containing Posaconazole as an Antifungal Drug for the Treatment of Fungal infection, Targeting topical, Ocular, Vaginal, and Systemic Delivery

This publication has 137 references indexed in Scilit:

• Novel Squalene Based Nanostructured Lipid Carriers of Ketoconazole for Enhanced Skin Penetration and Better Anti-Fungal Control: An In-Vitro, Ex-Vivo and In-Vivo Evaluation
  BioNanoScience, 2025
• Novel Hyaluronic Acid Based Adapalene Nano Vesicular Formulation for Enhanced anti-acne Control: A Sensitivity and Pharmacodynamic Analysis
  Journal of Cluster Science, 2025
• Formulation and Development of Posaconazole Loaded Controlled Release Nanosponge Topical Gel for the Treatment of Fungal Infection
  Journal of Pharmaceutical Innovation, 2025
• Advanced Solid Formulations For Vulvovaginal Candidiasis
  Pharmaceutical Research, 2022
• Chemical and biological aspects of posaconazole as a classic antifungal agent with non-classical properties: highlighting a tetrahydrofuran-based drug toward generation of new drugs
  Medicinal Chemistry Research, 2022
• Antifungal azoles and azole resistance in the environment: current status and future perspectives—a review
  Reviews in Environmental Science and Bio/Technology, 2021
• Potent antifungal agents and use of nanocarriers to improve delivery to the infected site: A systematic review
  Journal of Basic Microbiology, 2021
• Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transfer
  View, 2021
• In Vitro and In Silico Analysis of Ascorbic Acid Towards Lanosterol 14-α-Demethylase Enzyme of Fluconazole-Resistant Candida albicans
  Current Microbiology, 2020
• Review of the New Delayed‐Release Oral Tablet and Intravenous Dosage Forms of Posaconazole
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2015